<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer-Verlag</PublisherName>
    <PublisherLocation>New York</PublisherLocation>
  </PublisherInfo>
  <Journal>
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12248</JournalID>
      <JournalElectronicISSN>1550-7416</JournalElectronicISSN>
      <JournalTitle>The AAPS Journal</JournalTitle>
      <JournalAbbreviatedTitle>AAPS J</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="F" Type="Primary">Pharmacy</JournalSubject>
        <JournalSubject Code="F00008" Priority="1" Type="Secondary">Pharmacy</JournalSubject>
        <JournalSubject Code="B21007" Priority="2" Type="Secondary">Pharmacology/Toxicology</JournalSubject>
        <JournalSubject Code="C12002" Priority="3" Type="Secondary">Biotechnology</JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume>
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>7</VolumeIDStart>
        <VolumeIDEnd>7</VolumeIDEnd>
        <VolumeIssueCount>4</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular">
        <IssueInfo TocLevels="0">
          <IssueIDStart>3</IssueIDStart>
          <IssueIDEnd>3</IssueIDEnd>
          <IssueArticleCount>25</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2005</Year>
              <Month>9</Month>
            </CoverDate>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
            <CopyrightYear>2005</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="Art20">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>73693</ArticleID>
            <ArticleDOI>10.1208/aapsj070370</ArticleDOI>
            <ArticleSequenceNumber>20</ArticleSequenceNumber>
            <ArticleTitle Language="En">Population pharmacokinetics of recombinant factor XIII in cynomolgus monkeys</ArticleTitle>
            <ArticleFirstPage>E693</ArticleFirstPage>
            <ArticleLastPage>E703</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2008</Year>
                <Month>1</Month>
                <Day>23</Day>
              </RegistrationDate>
              <Received>
                <Year>2004</Year>
                <Month>11</Month>
                <Day>3</Day>
              </Received>
              <Accepted>
                <Year>2005</Year>
                <Month>8</Month>
                <Day>18</Day>
              </Accepted>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
              <CopyrightYear>2005</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
            <ArticleContext>
              <JournalID>12248</JournalID>
              <VolumeIDStart>7</VolumeIDStart>
              <VolumeIDEnd>7</VolumeIDEnd>
              <IssueIDStart>3</IssueIDStart>
              <IssueIDEnd>3</IssueIDEnd>
            </ArticleContext>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1" PresentAffiliationID="Aff2">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Michael</GivenName>
                  <GivenName>G.</GivenName>
                  <FamilyName>Dodds</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff2">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Jennifer</GivenName>
                  <GivenName>E.</GivenName>
                  <FamilyName>Visich</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Paolo</GivenName>
                  <FamilyName>Vicini</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>(206) 616-1133</Phone>
                  <Fax>(206) 543-3081</Fax>
                  <Email>vicini@u.washington.edu</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>Resource Facility for Population Kinetics, Department of Bioengineering</OrgDivision>
                <OrgName>University of Washington</OrgName>
                <OrgAddress>
                  <Street>Aerospace Research 241</Street>
                  <Postbox>Box 352255</Postbox>
                  <Postcode>98195-2255</Postcode>
                  <City>Seattle</City>
                  <State>WA</State>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff2">
                <OrgName>ZymoGenetics Inc</OrgName>
                <OrgAddress>
                  <City>Seattle</City>
                  <State>Washington</State>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>Hemostasis in humans and other animals is a complex process that controls blood loss after a vascular injury. Factor XIII (FXIII) stabilizes clots primarily by cross-linking fibrin, thus protecting a newly formed clot from fibrinolysis by plasmin. Congenital deficiencies in humans involving FXIII are associated with delayed bleeding and wound healing and severe spontaneous hemorrhaging. These symptoms can be alleviated by intravenous administration of enriched FXIII plasma fractions. Circulating plasma FXIII is found as a heterotetramer that dissociates in the presence of calcium and thrombin into an active dimer and 2 inactive monomers. The recombinant FXIII under investigation is the active dimer alone. A 3-compartment, nonlinear population pharmacokinetic model was implemented in NON-MEM V and then used to analyze data from preclinical studies in cynomolgus monkeys. The model simultaneously describes endogenous production of dimer (0.622 μg kg<Superscript>−1</Superscript> hr<Superscript>−1</Superscript>) and monomer (12.1 μg kg<Superscript>−1</Superscript> hr<Superscript>−1</Superscript>), and the administration of recombinant dimer. The model incorporates the rate and extent of complexation of recombinant dimer with available endogenous monomer (6.59 mg<Superscript>−1</Superscript> kg hr<Superscript>−1</Superscript>) to form the heterotetramer. Half-lives for dimer, heterotetramer, and monomer (3.33 hours, 2.83 days, and 3.94 hours for A<Subscript>2</Subscript>, A<Subscript>2</Subscript>B<Subscript>2</Subscript>, and B, respectively) were estimated, along with their variability in the population studied.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Keywords</Heading>
              <Keyword>pharmacokinetics</Keyword>
              <Keyword>modeling</Keyword>
              <Keyword>FXIII</Keyword>
              <Keyword>population kinetics</Keyword>
            </KeywordGroup>
            <ArticleNote Type="Misc">
              <SimplePara>Published: October 27, 2005</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <BodyRef FileRef="BodyRef/PDF/12248_2008_Article_73693.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Takahashi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Takahashi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FW</Initials>
                    <FamilyName>Putnam</FamilyName>
                  </BibAuthorName>
                  <Year>1986</Year>
                  <ArticleTitle Language="En">Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>83</VolumeID>
                  <FirstPage>8019</FirstPage>
                  <LastPage>8023</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2877456</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.83.21.8019</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL2sXivFejtg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Takahashi N, Takahashi Y, Putnam FW. Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1986;83:8019–8023.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Saito</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Asakura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Yoshida</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1990</Year>
                  <ArticleTitle Language="En">A familial factor XIII subunit B deficiency</ArticleTitle>
                  <JournalTitle>Br J Haematol</JournalTitle>
                  <VolumeID>74</VolumeID>
                  <FirstPage>290</FirstPage>
                  <LastPage>294</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2334637</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1365-2141.1990.tb02585.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK3c3ktFOqsg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Saito M, Asakura H, Yoshida T, et al. A familial factor XIII subunit B deficiency.<Emphasis Type="Italic">Br J Haematol</Emphasis>. 1990;74:290–294.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Sakata</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Aoki</FamilyName>
                  </BibAuthorName>
                  <Year>1980</Year>
                  <ArticleTitle Language="En">Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor</ArticleTitle>
                  <JournalTitle>J Clin Invest</JournalTitle>
                  <VolumeID>65</VolumeID>
                  <FirstPage>290</FirstPage>
                  <LastPage>297</LastPage>
                  <Occurrence Type="PID">
                    <Handle>6444305</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1172/JCI109671</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL3cXht1Gqsb4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sakata Y, Aoki N. Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.<Emphasis Type="Italic">J Clin Invest</Emphasis>. 1980;65:290–297.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Muszbek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VC</Initials>
                    <FamilyName>Yee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Z</Initials>
                    <FamilyName>Hevessy</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Blood coagulation factor XIII: structure and function</ArticleTitle>
                  <JournalTitle>Thromb Res</JournalTitle>
                  <VolumeID>94</VolumeID>
                  <FirstPage>271</FirstPage>
                  <LastPage>305</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10379818</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0049-3848(99)00023-7</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXjslGhsb0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Muszbek L, Yee VC, Hevessy Z. Blood coagulation factor XIII: structure and function.<Emphasis Type="Italic">Thromb Res</Emphasis>. 1999;94:271–305.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SS</Initials>
                    <FamilyName>Acharya</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Coughlin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DM</Initials>
                    <FamilyName>Dimichele</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">North American Rare Bleeding Disorder Study Group. Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias</ArticleTitle>
                  <JournalTitle>J Thromb Haemost</JournalTitle>
                  <VolumeID>2</VolumeID>
                  <FirstPage>248</FirstPage>
                  <LastPage>256</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14995986</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1538-7836.2003.t01-1-00553.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXktVGgu78%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Acharya SS, Coughlin A, Dimichele DM. North American Rare Bleeding Disorder Study Group. Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias.<Emphasis Type="Italic">J Thromb Haemost</Emphasis>. 2004;2:248–256.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Wolpl</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Lattke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PG</Initials>
                    <FamilyName>Board</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1987</Year>
                  <ArticleTitle Language="En">Coagulation factor XIII A and B subunits in bone marrow and liver transplantation</ArticleTitle>
                  <JournalTitle>Transplantation</JournalTitle>
                  <VolumeID>43</VolumeID>
                  <FirstPage>151</FirstPage>
                  <LastPage>153</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3541316</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL2s%2FpsFamtg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00007890-198701000-00032</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wolpl A, Lattke H, Board PG, et al. Coagulation factor XIII A and B subunits in bone marrow and liver transplantation.<Emphasis Type="Italic">Transplantation</Emphasis>. 1987;43:151–153.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Nagy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Henriksson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>McDonagh</FamilyName>
                  </BibAuthorName>
                  <Year>1986</Year>
                  <ArticleTitle Language="En">Biosynthesis of factor XIII B subunit by human hepatoma cell lines</ArticleTitle>
                  <JournalTitle>Blood</JournalTitle>
                  <VolumeID>68</VolumeID>
                  <FirstPage>1272</FirstPage>
                  <LastPage>1279</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3022846</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL2sXmsVykuw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nagy JA, Henriksson P, McDonagh J. Biosynthesis of factor XIII B subunit by human hepatoma cell lines.<Emphasis Type="Italic">Blood</Emphasis>. 1986;68:1272–1279.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibBook>
                  <InstitutionalAuthorName>Institute of Laboratory Animal Resources, Commission on Life Sciences</InstitutionalAuthorName>
                  <Year>1996</Year>
                  <BookTitle>Guide for the care and use of laboratory animals</BookTitle>
                  <PublisherName>National Research Council, National Academy Press</PublisherName>
                  <PublisherLocation>Washington, DC</PublisherLocation>
                </BibBook>
                <BibUnstructured>Institute of Laboratory Animal Resources, Commission on Life Sciences.<Emphasis Type="Italic">Guide for the care and use of laboratory animals</Emphasis>. Washington, DC: National Research Council, National Academy Press; 1996.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Radek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Jeong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Wilson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Lorand</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Association of A subunits of recombinant placental factor XIII with the native carrier B subunits from human plasma</ArticleTitle>
                  <JournalTitle>Biochemistry</JournalTitle>
                  <VolumeID>32</VolumeID>
                  <FirstPage>3527</FirstPage>
                  <LastPage>3534</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8466897</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/bi00065a002</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXit12jtbg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Radek JT, Jeong JM, Wilson J, Lorand L. Association of A subunits of recombinant placental factor XIII with the native carrier B subunits from human plasma.<Emphasis Type="Italic">Biochemistry</Emphasis>. 1993;32:3527–3534.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibBook>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Jacquez</FamilyName>
                  </BibAuthorName>
                  <Year>1985</Year>
                  <BookTitle>Compartmental Analysis in Biology and Medicine</BookTitle>
                  <PublisherName>The University of Michigan Press</PublisherName>
                  <PublisherLocation>Ann Arbor, MI</PublisherLocation>
                </BibBook>
                <BibUnstructured>Jacquez JA.<Emphasis Type="Italic">Compartmental Analysis in Biology and Medicine</Emphasis>. Ann Arbor, MI: The University of Michigan Press; 1985.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibUnstructured>US Food and Drug Administration, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research.<Emphasis Type="Italic">Guidance for Industry: Population pharmacokinetics</Emphasis>. 1999; Available at: www.fda.gov/cder/guidance/1852fnl.pdf.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SL</Initials>
                    <FamilyName>Beal</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LB</Initials>
                    <FamilyName>Sheiner</FamilyName>
                  </BibAuthorName>
                  <Year>1982</Year>
                  <ArticleTitle Language="En">Estimating Population Pharmacokinetics</ArticleTitle>
                  <JournalTitle>Crit Rev Biomed Eng</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>195</FirstPage>
                  <LastPage>222</LastPage>
                  <Occurrence Type="PID">
                    <Handle>6754254</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL3s%2Flt1arsA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Beal SL, Sheiner LB. Estimating Population Pharmacokinetics.<Emphasis Type="Italic">Crit Rev Biomed Eng</Emphasis>. 1982;8:195–222.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Rodeghiero</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Morbin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Barbui</FamilyName>
                  </BibAuthorName>
                  <Year>1981</Year>
                  <ArticleTitle Language="En">Subunit A of factor XIII regulates subunit B plasma concentration</ArticleTitle>
                  <JournalTitle>Thromb Haemost</JournalTitle>
                  <VolumeID>46</VolumeID>
                  <FirstPage>621</FirstPage>
                  <LastPage>622</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7314056</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL38%2FosFensg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rodeghiero F, Morbin M, Barbui T. Subunit A of factor XIII regulates subunit B plasma concentration.<Emphasis Type="Italic">Thromb Haemost</Emphasis>. 1981;46:621–622.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TC</Initials>
                    <FamilyName>Reynolds</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MD</Initials>
                    <FamilyName>Butine</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JE</Initials>
                    <FamilyName>Visich</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Safety, pharmacokinetics, and immunogenicity of single-dose rFXIII administration to healthy volunteers</ArticleTitle>
                  <JournalTitle>J Thromb Haemost</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <FirstPage>922</FirstPage>
                  <LastPage>928</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15869585</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1538-7836.2005.01224.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXltlOitLg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Reynolds TC, Butine MD, Visich JE, et al. Safety, pharmacokinetics, and immunogenicity of single-dose rFXIII administration to healthy volunteers.<Emphasis Type="Italic">J Thromb Haemost</Emphasis>. 2005;3:922–928.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
